Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.

SEARCH GUIDE  Download Search Tip PDF File

  • articleNo Access

    Nucleotide-driven packaging of a singlet oxygen generating porphyrin in an icosahedral virus

    Results are reported from investigations of the interactions between MS2 bacteriophages and a cationic porphyrin with potential use in photodynamic therapy. Based on the naturally strong binding between porphyrins and nucleic acids, it is suggested that this non-enveloped capsid could act as a self-loading, nanoscale carrier of porphyrins. By applying size exclusion chromatography in conjunction with UV-vis and fluorescence spectroscopy, it is demonstrated that approximately 250 porphyrin molecules could associate and co-elute with a single capsid. Additionally, there is an observed red shift in the Soret peak of the porphyrin, indicating that the majority of the cationic porphyrin is capable of interacting with RNA on the interior of the capsid. It is also observed that removal of RNA from the interior of the MS2 capsid significantly reduces loading capacity of the porphyrin. Furthermore, MS2 bacteriophages loaded with porphyrins were shown to photogenerate singlet oxygen. These findings suggest that icosahedral viruses, such as MS2 bacteriophages, are able to function as self-packaging "nanoscale containers" and efficiently load cationic porphyrins, with potential benefits in areas such as targeted photodynamic therapy.

  • chapterNo Access

    IS CRYSTALLIZATION A “BOTTLENECK” OF MODERN STRUCTURAL CRYSTALLOMIC?

    Crystallization is recognized among structural biologists as a necessary process before three-dimensional structure can be solved at an atomic level. Crystallization has a dose of mysticism among protein chemist. Some treats it as an “art” and others as “black magic”. These concepts aroused from a limited knowledge in the physical chemistry of proteins in solution. Crystallization appears only in a metastable state. To define crystallization conditions the experiments are guided either by a chance search or by dedicated factorial design. Here we will briefly describe a factorial design method to rationally approach the metastable state. In summary, there is nothing mysterious in crystallization of biological macromolecules, and the success can often be achieved within a limited number of experiments.